0001179110-21-010610.txt : 20211203 0001179110-21-010610.hdr.sgml : 20211203 20211203172825 ACCESSION NUMBER: 0001179110-21-010610 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211201 FILED AS OF DATE: 20211203 DATE AS OF CHANGE: 20211203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Payson Norman CENTRAL INDEX KEY: 0000898544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39100 FILM NUMBER: 211471252 MAIL ADDRESS: STREET 1: 800 N. GLEBE ROAD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER NAME: FORMER CONFORMED NAME: PAYSON NORMAN C MD DATE OF NAME CHANGE: 19930310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Progyny, Inc. CENTRAL INDEX KEY: 0001551306 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 272220139 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 212-888-3124 MAIL ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn, Inc. DATE OF NAME CHANGE: 20150318 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn Inc DATE OF NAME CHANGE: 20120601 4 1 edgar.xml FORM 4 - X0306 4 2021-12-01 0 0001551306 Progyny, Inc. PGNY 0000898544 Payson Norman C/O PROGYNY, INC. 1359 BROADWAY, 2ND FL NEW YORK NY 10018 1 0 0 0 Common Stock 2021-12-01 4 M 0 225000 1.45 A 233652 D Common Stock 2021-12-01 4 S 0 2097 48.24 D 570229 I See footnote Common Stock 2021-12-01 4 S 0 2233 49.42 D 567996 I See footnote Common Stock 2021-12-01 4 S 0 1200 50.68 D 566796 I See footnote Common Stockq 2021-12-01 4 S 0 1402 51.54 D 565394 I See footnote Common Stock 2021-12-01 4 S 0 1398 52.24 D 563996 I See footnote Common Stock 2021-12-02 4 S 0 5046 48.47 D 558950 I See footnote Common Stock 2021-12-02 4 S 0 2984 49.19 D 555966 I See footnote Common Stock 2021-12-02 4 S 0 300 50.26 D 555666 I See footnote Common Stock 122493 I See footnote Stock Option (right to buy) 1.45 2021-12-01 4 M 0 225000 0 D 2026-12-07 Common Stock 225000 36223 D Adjusted due to rounding error. Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.91 to $47.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12). The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.99 to $49.86, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.15 to $51.12, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.17 to $52.155, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.165 to $52.4, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.89 to 48.87, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.9 to $49.885, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.2 to $50.33, inclusive. The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities. One forty-eighth (1/48th) of the shares subject to the Option vested or shall vest each month commencing January 2, 2017, subject to the Reporting Person continuing to provide service through each such date. /s/ Jennifer Bealer, Attorney-in-Fact 2021-12-03